Skip to main content

Month: April 2022

With 19.7% CAGR, Clear Aligners Market Size worth USD 10.04 Billion in 2028

Key Prominent Players Covered in the Clear Aligners Market are Align Technology, Inc. (San Jose, U.S.) , 3M (Maplewood), U.S.) , Institut Straumann AG (Basel, Switzerland) , Ormco Corporation (Envista) (Brea, U.S.) , 3Shape A/S (Copenhagen, Denmark) , Dentsply Sirona (York, U.S.) , Argen Corporation (San Diego, U.S.) , Henry Schein, Inc. (Melville, U.S.) Pune, India, April 19, 2022 (GLOBE NEWSWIRE) — The global clear aligners market size is expected to reach USD 10.04 billion by 2028, exhibiting a CAGR of 19.7% during the forecast period. The surging demand for clear aligners in orthodontic treatment can have a tremendous impact on the market growth, states Fortune Business Insights in a report titled, “Clear Aligners Market, 2021-2028.” The market stood at USD 2.41 billion in 2020. Key Development: January 2021: Ormco Corporation...

Continue reading

With 6.2% CAGR, Dental Implants Market Size worth USD 5.71 Billion in 2028

Key Players Covered in the Dental Implants Market Research Report Are Institut Straumann AG (Basel, Switzerland), Danaher (Washington, D.C., United States), Dentsply Sirona (Pennsylvania, United States), Henry Schein, Inc. (New York, United States), Zimmer Biomet (Indiana, United States), Osstem Implant (Seoul, South Korea), BioHorizons (Alabama, United States), CeraRoot SL. (Barcelona, Spain) Pune, India, April 19, 2022 (GLOBE NEWSWIRE) — The global Dental Implants Market size is estimated to reach USD 5.71 billion by 2028. Fortune Business Insights™, in its report titled, Dental Implants Market, 2021-2028.”, mentions that the market stood at USD 3.66 billion in 2020 and is likely to exhibit a CAGR of 6.2% between 2021 and 2028. As per our researchers, the growth is subjected to the rising consciousness regarding oral hygiene...

Continue reading

With 6.4% CAGR, Dentures Market Size worth USD 3.38 Billion in 2028

Dentures Market Covered By Key Companies – Dentsply Sirona (York, Pennsylvania, U.S.), Zimmer Biomet , Ivoclar Vivadent , SHOFU INC. , Mitsui chemicals Inc, Modern Dental Group Limited ,C. dental (Tokyo, Japan), Global Dental Science (Arizona, U.S.), H. Dental Care, VITA Zahnfabrik Pune, India, April 19, 2022 (GLOBE NEWSWIRE) — The Global Dentures Market size is expected to gain momentum by reaching USD 3.38 billion by 2028 while exhibiting a CAGR of 6.4% between 2021 to 2028. In its report titled “Dentures Market, 2021-2028,” Fortune Business Insights mentions that the market stood at USD 2.09 billion in 2020. Dentures are tailor-made tools used to replace an individual’s missing teeth and restore the appearance and oral functions. Moreover, the rising number of edentulism cases is leading to the increasing...

Continue reading

Staffing 360 Solutions Agrees to Acquire Headway Workforce Solutions

Acquisition Would Expand Offerings Nationwide WithEnhanced Cutting-Edge Tools and Technologies NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) — Staffing 360 Solutions, Inc. (NASDAQ: STAF), a company executing an international buy-integrate-build strategy through the acquisition of staffing organizations in the United States and the United Kingdom, announced today that it has signed an agreement to acquire Headway Workforce Solutions for up to approximately $14 million in a combination of stock and cash. The acquisition is subject to the satisfaction of certain closing conditions. Upon closing, $9 million will be paid through issuance of shares of preferred stock that are convertible into approximately 3.5 million common shares, and up to $5 million cash through an earn-out. With a 35-year history and a national reach of human capital...

Continue reading

SMG Industries, Inc. Reports Financial Results for Fiscal Year 2021

Transportation Services Company Reports $52.1 million in annual revenue for 2021, net of discontinued operations, an increase of $25.4 million, or 95% from 2020 HOUSTON, TX, April 19, 2022 (GLOBE NEWSWIRE) — via NewMediaWire– SMG Industries, Inc. (the “Company”) (OTCQB:SMGI), a growth-oriented transportation services company focused on the domestic infrastructure logistics market, today reported financial results for the full year ended December 31, 2021 and released its 2021 Annual Report on Form 10-K. Fiscal Year 2021 HighlightsNet of discontinued operations, Revenues increased to $52.1 million in fiscal year 2021, or about 95% from $25.4 million in fiscal year 2020. Adjusted Gross Margins, after deducting 2021 depreciation expenses (a non-cash charge) of $5,398,529, were $4,797,938 for the year ended December 31, 2021....

Continue reading

Nordic Fibreboard AS Audited Annual Report 2021

On 18 April 2022, the Supervisory Board of Nordic Fibreboard AS approved the company’s audited annual report for 2021. OVERVIEW OF OPERATING RESULTS Consolidated net sales for 2021 were € 10.10 million (2020: € 10.27 million). Fibreboard sales for year 2021 were € 9.84 million, a 2% decrease from year 2020 sales of € 10.00 million. Main reason for such decline was due to the closure of the Püssi fibreboard factory in March 2020 triggered by the COVID-19 pandemic, as a result of which production volume decreased. The sales revenue in 2021 from real estate management was € 254 thousand (2020: € 212 thousand), the increase in sales revenue was due to the addition of tenant to the production facilities. There was no sales from the furniture retail in 2021, as the company ceased its active economic activity already on 31.01.2020. In 2020...

Continue reading

Dundee Corporation Signs Deal in Partnership With Aura Minerals to Develop and Participate in Future Cash Flows From the Borborema Mine

TORONTO, April 19, 2022 (GLOBE NEWSWIRE) — Dundee Corporation (TSX: DC.A) (the “Corporation” or “Dundee”) today announces its wholly-owned subsidiary, Dundee Resources Limited (“Dundee Resources”), has entered into a binding Cooperation and Commitment Deed with Aura Minerals Inc. (TSX: ORA) (“Aura”) that will see Dundee Resources, a 19.3 percent shareholder in Big River Gold Limited (ASX: BRV) (“Big River”), retain a 20.0 percent interest in Big River through a joint venture arrangement with Aura, subject to certain conditions. In conjunction with this announcement, Aura unveils plans to acquire 100 percent of Big River. Transaction HighlightsAura to acquire 100 percent of Big River and form an 80/20 percent joint venture with Dundee Resources. Big River shareholders (other than Dundee Resources) to receive A$0.36 in cash consideration...

Continue reading

Mobix Labs to Acquire Advanced Interconnect Technologies

Deal to be Immediately Accretive, Transaction Opens New Markets in Military, Defense and Space IRVINE, Calif., April 19, 2022 (GLOBE NEWSWIRE) — Mobix Labs Inc., a global connectivity solutions provider for wireless mmWave 5G and wired high bandwidth cable networks, today announced it has signed a definitive agreement to acquire Advanced Interconnect Technologies (AIT), a St. Cloud, Minnesota-based manufacturer and product development firm serving the military, defense, and commercial air and space industries. Terms were not disclosed. “We are very excited about adding Advanced Interconnect Technologies to our growing company,” said Fabian Battaglia, CEO of Mobix Labs. “Bringing AIT into the Mobix Labs portfolio as part of our acquisition strategy allows us to offer manufacturing and design services to existing global customers,...

Continue reading

PetMeds® Announces Exclusive Partnership with Vetster for Pet Telemedicine

New agreement with the fastest-growing veterinary telehealth and pet-care marketplace provides 24/7 access to over 70,000 veterinarians for PetMeds®’ millions of pet parents. DELRAY BEACH, Fla., April 19, 2022 (GLOBE NEWSWIRE) — PetMed Express, Inc. (NASDAQ: PETS), Your Trusted Pet Health Expert, today announced an exclusive partnership and investment with Vetster Inc., a leading veterinary telemedicine and pet-care marketplace. The deal unlocks access to virtual, around-the-clock pet healthcare for PetMeds®’ 2 million-plus pet parents as well as integrated fulfillment of pet medications for veterinarians and vet clinics. The move further positions PetMeds as the premier source for pet health online.  Through the agreement — the first of its kind to enable pet telemedicine on a mass scale — PetMeds becomes the exclusive e-commerce...

Continue reading

TRACON Pharmaceuticals Announces Amended ENVASARC Protocol Approved and Open at all 30 Clinical Sites in the U.S. and U.K.

Expects to Report Results of Independent Data Monitoring Committee (IDMC) Mandated Interim Safety Reviews and Interim Efficacy Review in the Second Half of 2022 SAN DIEGO, April 19, 2022 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States, today announced that the amended ENVASARC protocol approved by the U.S. Food and Drug Administration (“FDA”) in February has now been approved by institutional review boards or ethics committees at all 30 clinical sites: 29 in the United States and one in the United Kingdom. In February,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.